CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
Hyaluronic Acid filler +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02868749
NCT02868749N/ACompleted
CompareCT.gov

Comparative Clinical, Histological and Ultrasound Pilot Study of Two Hyaluronic Acid Gel Fillers, Designed for Deep Injection, in Adipose Tissue

Vandeputte, Joan, M.D.·interventional·Posted Aug 16, 2016·Updated Jan 23, 2019

In Brief

A clinical study evaluating Hyaluronic Acid filler for Atrophy. Completed, enrolled 5 participants across 2 sites.

Detailed Summary

This study is a single-blind intra-individual comparative study to evaluate the short and medium term tissue response after the injection of 2 brands of hyaluronic acid gels (HA), designed for deep injection, that have been used for several years on a worldwide scale.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrophy
CountriesBelgium
CollaboratorsUniversitair Ziekenhuis Brussel

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 16, 2016
Enrollment StartMar 22, 2017
Primary CompletionApr 11, 2018
Study CompletionSep 30, 2018
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.9 years ago

Interventions

Hyaluronic Acid fillerdevice

Linear retrograde, subcutaneous injection of 0,5 ml of hyaluronic acid gel in one side of the abdomen or one breast, 3 weeks to 4 months before the surgery.

Hyaluronic Acid fillerdevice

Linear retrograde, subcutaneous injection of 0,5 ml of hyaluronic acid gel in other side of the abdomen or other breast, 5 to 9 days before the surgery.